Showing 2201-2210 of 20882 results for "".
- Innovations in Obesity Management: The Clinical Impact of Tirzepatidehttps://reachmd.com/news/innovations-in-obesity-management-the-clinical-impact-of-tirzepatide/2475403/Although global obesity rates continue to rise, innovative pharmacological agents such as tirzepatide are capturing clinical attention for their ability to suppress appetite and drive substantial weight loss, complementing existing lifestyle
- Novel Biomarkers for Early Detection and Intervention in Psychosis and Depressionhttps://reachmd.com/news/novel-biomarkers-for-early-detection-and-intervention-in-psychosis-and-depression/2475398/Exploring novel biomarkers for early detection and improved intervention in psychosis and depression, recent data highlight grip strength and inflammatory profiles as windows into psychiatric pathophysiology. Distinguishing incipient p
- Evolving Strategies in Obesity Care: Integrating Holistic and Innovative Approacheshttps://reachmd.com/news/evolving-strategies-in-obesity-care-integrating-holistic-and-innovative-approaches/2475399/Evolving Strategies in Obesity Care: Integrating Holistic and Innovative Approaches With over 40% of US adults classified as obese, clinicians are rethinking strategies that focus exclusively on weight reduction, embra
- High Defect Rate of Cancer Medications in Sub-Saharan Africa: Urgent Need for Innovative Solutionshttps://reachmd.com/news/high-defect-rate-of-cancer-medications-in-sub-saharan-africa-urgent-need-for-innovative-solutions/2475404/The high defect rate of cancer medications in sub-Saharan Africa is directly impacting patient outcomes and safety, demanding urgent attention and innovative responses. Research from the University of Notre Dame highlights that 1 in 6
- The Evolving Role of JAK Inhibitors: Upadacitinib’s Impact on Giant Cell Arteritishttps://reachmd.com/news/the-evolving-role-of-jak-inhibitors-upadacitinibs-impact-on-giant-cell-arteritis/2475405/Upadacitinib, a Janus kinase (JAK) inhibitor, has shown efficacy in managing giant cell arteritis by achieving sustained remission in clinical trials, potentially providing an alternativ
- Advanced Imaging and Optical Strategies in Predicting Myopia Progressionhttps://reachmd.com/news/advanced-imaging-and-optical-strategies-in-predicting-myopia-progression/2475410/A recent longitudinal study published June 16, 2025, in the American Journal of Ophthalmology offers new insights into how peripheral vision may influe
- AI Innovations Reshape Radiology: Breast Cancer and MRI Breakthroughshttps://reachmd.com/news/ai-innovations-reshape-radiology-breast-cancer-and-mri-breakthroughs/2475402/Radiologists seeking to close diagnostic blind spots in both breast cancer detection and MRI scans are increasingly leveraging AI diagnostic tools, as recent findings from AI for breast cancer detection reveal its capacity to detect and local
- Integrating Genetic Ancestry and Precision Oncologyhttps://reachmd.com/news/integrating-genetic-ancestry-and-precision-oncology/2475328/In the field of oncology, genetic profiling allows for more tailored treatments to individuals' genetic profiles, which is helping to refine prognosis and therapy strategies. Clinicians are confronted with striking variability in outco
- AI Implants: Transforming Chronic Pain Management Beyond Opioidshttps://reachmd.com/news/ai-implants-transforming-chronic-pain-management-beyond-opioids/2475329/AI-driven pain management technologies are emerging as potential non-opioid approaches to chronic pain relief. However, these implantable AI systems are still in the early stages of development and require further clinical validation to asses
- Advanced PET Imaging in Cardiology: Early Detection and Intervention for Non-Ischemic Myocardial Injuryhttps://reachmd.com/news/advanced-pet-imaging-in-cardiology-early-detection-and-intervention-for-non-ischemic-myocardial-injury/2475333/Advanced PET imaging techniques are enhancing cardiology by detecting early non-ischemic myocardial injury through fibroblast activation, facilitating timely intervention before irreversible remodeling. Non-ischemic cardiomyopathy pres